Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Payers' Perspectives
Stakeholder Integration Needed to Address a Flawed Reimbursement System
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Breast Cancer
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
Phoebe Starr
Read More
Breast Cancer
Less May Be “More” with Zoledronic Acid
Caroline Helwick
Read More
Breast Cancer
Adjuvant Exemestane More Effective than Tamoxifen in Early-Stage Breast Cancer
Wayne Kuznar
Read More
Multiple Myeloma
Novel Drug Classes Make News in Multiple Myeloma
Caroline Helwick
Read More
Lung Cancer
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
Wayne Kuznar
Read More
FDA Approvals
Idelalisib Approved for 3 Types of Hematologic Cancers
Read More
FDA Approvals
Belinostat Approved for Peripheral T-Cell Lymphoma
Read More
FDA Approvals
Palonosetron Indicated for CINV Prevention in Pediatric Patients
Read More
FDA Approvals
Zykadia for Metastatic, ALK-Positive Lung Cancer
Read More
1
2
3
4
Page 1 of 4
Results 1 - 10 of 32